Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol.

Saved in:
Bibliographic Details
Title: Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol.
Authors: Gregory JW; Division of Population Medicine, Cardiff University, Cardiff, South Glamorgan, UK., Carter K; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK k.carter@swansea.ac.uk., Cheung WY; Diabetes Research Unit Cymru (DRUC), Swansea University, Swansea, West Glamorgan, UK., Holland G; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK., Bowen-Morris J; Diabetes Research Group, Cardiff University, Cardiff, South Glamorgan, UK., Luzio S; Diabetes Research Unit Cymru (DRUC), Swansea University, Swansea, West Glamorgan, UK., Dunseath G; Diabetes Research Unit Cymru (DRUC), Swansea University, Swansea, West Glamorgan, UK., Tree T; Peter Gorer Department of Immunobiology, King's College London, London, UK.; National Institute for Health Research (NIHR) Biomedical Research Center (BRC), Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Yang JHM; Peter Gorer Department of Immunobiology, King's College London, London, UK.; National Institute for Health Research (NIHR) Biomedical Research Center (BRC), Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK., Marwaha A; Department of Molecular Genetics, Cumming School of Medicine, The University of Calgary, Calgary, Alberta, Canada., Ali MA; Diabetes Research Group, Cardiff University, Cardiff, South Glamorgan, UK., Bashir N; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK., Hutchings HA; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK., Fegan GW; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK., Stenson R; Diabetes Research Group, Cardiff University, Cardiff, South Glamorgan, UK., Hiles S; Swansea Trials Unit (STU), Swansea University, Swansea, West Glamorgan, UK., Marques-Jones S; Patient and Public Representative, Ammanford, West Glamorgan, UK., Brown A; Patient and Public Representative, Cardiff, UK., Tatovic D; Diabetes Research Group, Cardiff University, Cardiff, South Glamorgan, UK., Dayan C; Diabetes Research Group, Cardiff University, Cardiff, South Glamorgan, UK.
Source: BMJ open [BMJ Open] 2021 Oct 18; Vol. 11 (10), pp. e049595. Date of Electronic Publication: 2021 Oct 18.
Publication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2044-6055
DOI:10.1136/bmjopen-2021-049595